Veriheal

AUGUST 31, 2020

Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death. Program between St. Bonaventure University and George Washington University School of Medicine. .

Research and Development 117

Research and Development Education Agriculture Patients 117

Cannabis Law Report

MAY 14, 2022

Medicinal cannabis products have been available since 2018. Cannabis-based products for medicinal use, or “CBPMs”, have been available for prescription in the UK since 2018; however, access is strictly limited through existing and bespoke regulatory controls. million patients currently accessing cannabis through the illicit market.

Access 52

Access CBD Research and Development Medicine 52

The Joint Blog

NOVEMBER 4, 2019

” However, as noted by NORML, around half of respondents “expressed discomfort in talking to their patients about medical cannabis options, a finding that is also consistent with prior data. Healthcare providers play a critical role in facilitating patient access to medical cannabis. A majority (>?50%)

Therapy 42

Therapy Clinical Trials Conditions Patients 42

Cannabis Law Report

SEPTEMBER 24, 2019

T he EU has approved for the first time the use of a medicinal cannabis product aimed at patients with two rare, but severe, forms of childhood epilepsy. The use of ones containing THC was legalised across the UK in November 2018. Here is the BBC report and below you will find the full press release from GW Pharmaceuticals.

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

The Blunt Truth

AUGUST 13, 2019

Since the passage of the Farm Bill in December of 2018 , there has been a marked uptick in interest in the cannabidiol (CBD) space from businesses and users alike. To understand the breadth of issues and gather data on safety we have conducted a public hearing, reviewed the medical literature, and have an open public docket.”.

CBD 80

CBD Food Seed-To-Sale Wellness and Beauty 80

The Joint Blog

APRIL 17, 2020

In 2018, ProCon.org has estimated well over 3.5M Medical cannabis is typically prescribed for patients with severe conditions including inflammatory conditions (e.g., Additionally, there are variations based on the patients at a physiology, route of administration, and administration practices level.

Events 48

Events THC Chronic Pain Sleep 48

Cannabis Law Report

JULY 23, 2019

Therefore, on 31 December 2018 the commission sent a legislative report to Maryland’s General Assembly that laid the groundwork for several bills submitted during the 2019 legislative session. Some states require mandatory warning statements in advertisements for medical cannabis. a playground, recreation centre, library or public park.

Law 40

Law Clinical Trials CBD Edibles 40

The Cannigma

MARCH 25, 2021

In nursing school, I wrote my dissertation on the role of the nurse when caring for patients using cannabis therapeutically, knowing that nurses are often the first healthcare professional to whom patients disclose their cannabis use. I remain in awe of these patients to this day.

Patients 145

Patients Clinical Trials Medicine Events 145

The Cannigma

JUNE 15, 2021

Some healthcare professionals are already encouraged by what is known, much of it anecdotal accounts from patients in their practices. The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. Easy access.

CBD 122

CBD Research and Development Epilepsy Extraction 122

The Cannigma

JANUARY 13, 2023

The fact that migraine is now ranked as the second leading cause of years lived with disability illustrates the magnitude of the negative impact of the disease to patients and their ability to function normally. A 2019 retrospective review of 316 patients found that medical cannabis improved the experience of 88.3%

Terpenes 132

Terpenes Strains THC Treatment 132

CannaTech

SEPTEMBER 23, 2019

The acceptance of medical cannabis by clinicians, researchers and government bodies is fairly universal, and patients have benefited from widespread access to full-spectrum cannabis in flower and oil form. Israel’s approach to cannabis has contributed to reducing stigma and increasing access for patients around the world.

Patients 79

Patients Policy Clinical Trials Research and Development 79

Project CBD

FEBRUARY 28, 2023

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. Silver Spring, MD: US Food and Drug Administration; June 25, 2018.

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

OCTOBER 26, 2019

One such circumstance is a clinical trial. A clinical trial in Australia must have an Australian sponsor (whether it be an individual (e.g., Two of the avenues for supply of UTGs for clinical trials are the Clinical Trial Exemption (CTX) Scheme and the Clinical Trial Notification (CTN) Scheme.

Clinical Trials 45

Clinical Trials Medicine Research and Development Compliance 45

Cannabis Law Report

NOVEMBER 29, 2021

ATAI Life Sciences AG (NASDAQ: ATAI), the innovative mental health platform company I have started in 2018 and which is committed to unlocking the compelling potential of psychedelics, has announced this morning that it has bought an additional stake in COMPASS Pathways (NASDAQ: CMPS), bringing atai’s ownership in Compass beyond 20%.

Treatment 52

Treatment Clinical Trials Data Patients 52

Cannabis Law Report

JANUARY 3, 2022

(Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication and substance abuse, announces that the first patient has been dosed in a Phase 2 proof-of-concept clinical study investigating ANEB-001 as a potential treatment for acute cannabinoid intoxication.

Pharmaceutical 52

Pharmaceutical Cannabinoids Treatment Clinical Trials 52

Cannabis Law Report

JANUARY 9, 2019

Armed with their mission, in June 2018, Phoenix merged many of its partnership organisations together under the name Phoenix Life Sciences International Limited, placing expert botanists, biologists, industrial and organic chemists, medical doctors, researchers, packagers and distributors together under one roof. Photo: Google Maps.

Therapy 85

Therapy Clinical Trials Treatment Medicine 85

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. At the same time, the outlook on cannabis research data is largely positive. 2018 ; Frankhauser 2008 ).

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

APRIL 8, 2022

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. On May 3, 2021, our study of MDMA-assisted therapy for PTSD achieved successful results for patients with severe, chronic PTSD.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Cannabis Law Report

JULY 12, 2019

Access is clearly in demand from Londoners as there is already a waiting list of 150 patients at the London clinic ahead of its opening. The legislation was passed in June 2018 despite criticism from many concerned by the risks the drug may pose to users’ mental health. How controversial were the changes in the law?

Epilepsy 40

Epilepsy Medicine Clinical Trials Chronic Pain 40

Cannabis Law Report

MAY 13, 2019

Medical professionals want more information about medicinal cannabis before they start prescribing it to patients, a new study has found. Using a predetermined study protocol, PubMed, EMBASE, PsycINFO, CINAHL, and Scopus databases were searched for studies indexed up to the 1 st August 2018. Conclusion. Introduction.

Medicine 45

Medicine Research and Development Clinical Trials Data 45

CannaMD

OCTOBER 7, 2019

Besides going against all the classic “munchies/stoner” stereotypes, this finding is especially puzzling as cannabis is often used to increase weight gain in patients with medical conditions such as HIV/AIDS and cancer. So why are medical marijuana patients gaining weight when they need to, but losing weight when they don’t?

Marijuana 105

Marijuana Cannabinoids Patients Conditions 105

The Cannigma

FEBRUARY 1, 2023

Patients are often left to their own devices when looking into cannabis and cancer, given the lack of clinical evidence, and stigma surrounding the use of the plant as medicine. To date, very few human clinical trials have been conducted to assess the effectiveness of THC or CBD in treating cancer. The answer: Maybe!

Clinical Trials 145

Clinical Trials Research and Development Therapy Cannabinoids 145

SMPL

MAY 26, 2020

Miller spent the months after this meeting leading hundreds of CBD seminars for farmers; Dr. Kerr began informal patient surveys to track how CBD made people feel; and as he finished his book, Mr. Lee often traveled around with Mr. Laughter and Mr. Ringo’s high-CBD plants and seeds, spreading the gospel at pot shops across the West.

CBD 40

CBD Research and Development Pharmaceutical Seed-To-Sale 40

Green Relief

MAY 13, 2018

LEE ON MAY 02, 2018. A 2014 study found that traumatic brain injury ( TBI ) patients who tested positive for THC were more likely to survive with less impairment than TBI patients who abstained from marijuana. A positive THC screen is associated with decreased mortality in adult patients sustaining TBI ,” the study concluded.

THC 64

THC CBD Cannabinoids Research and Development 64

Cannabis Law Report

AUGUST 30, 2019

The US Department of Agriculture (USDA) has released new data indicating a substantial increase in the growth of US hemp production. Since the passage of the 2018 Farm Bill, industrial hemp production has increased by 368 percent among US farmers as demand for CBP products has drastically risen. Medical/Health.

Banking 45

Banking Research and Development Legislation Programs 45

Green Relief

MAY 12, 2018

LEE ON MAY 02, 2018. A 2014 study found that traumatic brain injury ( TBI ) patients who tested positive for THC were more likely to survive with less impairment than TBI patients who abstained from marijuana. A positive THC screen is associated with decreased mortality in adult patients sustaining TBI ,” the study concluded.

Research and Development 40

Research and Development Cannabinoids Therapy CBD 40

The Joint Blog

AUGUST 27, 2020

The study found that medical cannabis use is associated with less frequent hospitalizations among patients living with sickle cell disease (SCD). It’s titled Medical marijuana certification for patients with sickle cell disease: A report of a single center experience. The study was published in the journal Blood Advances.

Patients 49

Patients Clinical Trials Data Therapy 49

SpeedWeed

DECEMBER 28, 2018

In my defense, 2018 has been a wild ride in the world of weed, a 12-month timespan which truly could be called “the best of times and the worst of times,” or perhaps just the highest and lowest of times. The Top 10 Cannabis Stories of 2018. But until then, here are the buzzes and bummers 2018 had to offer.

Pharmaceutical 40

Pharmaceutical Research and Development Legalization CBD 40

Cannabis Law Report

OCTOBER 29, 2019

The PK data on cats shows there are differences in absorption between cats and dogs and that dosing may be different between these two species and that our chew form is likely to be more absorbable than oils in general. This data gives us confidence in the use of both the chew and the oils as effective means for delivering CBD to your pet.”.

Safety 45

Safety CBD Clinical Trials Oil 45

Freedom Leaf

JANUARY 10, 2018

“We’re actively working toward developing new genetics to work on efficacy and assist the patients in Israel still operating with our nurse-run clinics in order to better provide the right dosage and strains for the patients who are referred to us by the Ministry of Health,” Stephen Gardner, Tikun Olam’s chief marketing officer, tells Freedom Leaf.

Research and Development 49

Research and Development Clinical Trials Strains Patients 49

Puff Puff Post

DECEMBER 28, 2018

An official study is aimed to conclude in July of 2019, where we’ll see all the data which comes forth. A sample of 120 patients aged between 5 and 29 years old with mild to severe autism are currently being given two different cannabis oil formulas or placebo. 80 % of parents noticed a reduction in negative behaviors.

Treatment 76

Treatment Oil CBD Therapy 76

Cannabis Law Report

JULY 12, 2019

Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval. No hepatic side effects were noted.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73

Cannabis Law Report

JUNE 4, 2021

Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. Rick Doblin, Ph.D, in/rickdoblin/ [link]. Brian Muraresku. in/ingmargorman/ [link]. in/gpechenik/ [link]. James Keim. Mimosa Therapeutics.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51

Cannabis Law Report

OCTOBER 17, 2019

billion in 2018, and with a compound annual growth rate of 23.9%, is predicted to reach $66.3 Another researcher, New Frontier Data, pegged the global value of legal and illicit cannabis together at $340 billion in 2018. Prior to the Farm Bill’s implementation in 2018, US companies could import hemp fiber, but not the flower.

Law 40

Law Seed-To-Sale Hemp Recreational 40

NORML

JANUARY 28, 2019

It’s understandable lawmakers want reliable data before making a decision. The good news for Kentucky legislators is the data already i s available. The National Center for Biotechnology Information has summarized a group of FDA approved randomized clinical trials, finding evidence for cannabis as medicine.

Data 187

Data Clinical Trials Chronic Pain Medicine 187